Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Missed opportunities in the real-world genetic testing in BRCA gene variant carriers with cancers meeting NCCN criteria.

Gynecologic oncology - 1 Mar 2023

Lee Sarah S, Rajeev Pournami, Finning Skyler, Oh Cheongeun, Pothuri Bhavana

Abstract excerpt

OBJECTIVE: The objective of this study was to determine the proportion of patients meeting the National Comprehensive Cancer Network (NCCN)'s BRCA genetic testing criteria prior to a diagnosis of a BRCA-related cancer. METHODS: This was a cross-sectional study of patients with BRCA pathogenic variants and a diagnosis of a BRCA-related cancer. Patients were included if they had known dates of genetic testing and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Heterozygote

Share to Neoplasms

Source

Identifiers

PMID: 36610379
DOI: 10.1016/j.ygyno.2022.12.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Missed opportunities in the real-world genetic testing in BRCA gene variant carriers with cancers meeting NCCN criteria.PMID 36610379Read ↗

An analysis of the impact of annual cancer genetic testing guideline updates on a past patient population.Semantic proximity Read ↗

Consideration for Multigene Panel Testing Outside of Cancer-Specific Genetic Testing.Semantic proximity Read ↗

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.Semantic proximity Read ↗

Breast and Ovarian Cancer Among Individuals Undergoing BRCA1 and BRCA2 Testing.Semantic proximity Read ↗

Universal genetic counseling in breast cancer patients significantly improves overall testing rates and improves completion rates in subpopulations.Semantic proximity Read ↗

Germline Genetic Testing After Cancer DiagnosisSemantic proximity Read ↗

Genetic Counseling and Germline Testing in the Era of Tumor Sequencing: A Cohort StudySemantic proximity Read ↗

Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.Semantic proximity Read ↗

When, how and why BRCA1 and BRCA2 genetic testing is offered to patients who do not meet standard criteriaSemantic proximity Read ↗

Evaluating the NCCN Clinical Criteria for Recommending BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.Semantic proximity Read ↗

Identification of Patients at Elevated Cancer Risk through a Community-Based Genetic Testing Program.Semantic proximity Read ↗

Perioperative genetic testing and time to surgery in patients with breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.